查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466136

Cystatin C测量市场：按产品类型、检测法、样品类型、设定、应用和最终用户 - 2024-2030 年全球预测

Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

Cystatin C测量市场规模预计 2023 年为 4.2747 亿美元，2024 年将达到 4.5983 亿美元，预计 2030 年将达到 6.9741 亿美元，复合年增长率为 7.24%。

Cystatin C测量是一项用于测量Cystatin C水平的实验室测试，胱抑素 C 是一种几乎在体内每个细胞中产生的蛋白质。它在肌酸酐测量值误导的特殊情况下最有用。肾臟疾病盛行率的增加和人口老化增加了对Cystatin C测量的需求。此外，先进的自动化测试方法的引入增加了Cystatin C的可用性和临床采用，从而导致市场成长。相较之下，Cystatin C测量的製造成本较高且解释指南严格，这限制了其采用。然而，一些供应商正在投资研发来克服这个问题。此外，诊断技术的进步、新研究以及有关Cystatin C测量的临床指南的持续发布提供了巨大的市场成长机会。

主要市场统计
基准年[2023] 4.2747亿美元
预测年份 [2024] 4.5983亿美元
预测年份 [2030] 6.9741亿美元
复合年增长率（%） 7.24%

消费者偏好Cystatin C分析仪用于产品诊断和疾病监测

Cystatin C分析仪是医疗设备。该设备对于诊断和监测肾臟疾病等疾病至关重要。Cystatin C套件旨在准确测量细胞培养上清液、血清、血浆、唾液、尿液和人类乳中的人类胱抑素 C。Cystatin C试剂被公认为可提供准确、精确结果的最高品质试剂。这是实验室用来测量样本中Cystatin C浓度的化学物质。多种方法和格式为任何规模的实验室提供了弹性和选择。

方法 扩大使用酵素结合免疫吸附检测法(ELISA)Cystatin C测量

酵素结合免疫吸附检测法(ELISA) 是一种使用抗体检测和定量样本中胱抑素 c 浓度的方法。 ELISA 方法以其敏感性和特异性而闻名，是临床实验室广泛使用的一种方法，用于评估Cystatin C水平作为肾功能的标记。Cystatin C的化学冷光免疫检测具有高灵敏度、宽动态范围，通常是自动化的，可实现高效的高通量测试。由于其定量Cystatin C水平的精确性和准确性，它通常用于临床实验室。萤光使用萤光染料或蛋白质来标记Cystatin C抗体，并用显微镜或特殊设备检测萤光。它在需要目视确认Cystatin C存在的研究环境和某些临床情况下非常有用。颗粒增强比浊免疫检测(PENIA)具有较高的灵敏度和准确性，适用于低浓度样品，由于其在定量Cystatin C方面的准确性和可靠性而广泛应用于临床实验室，特别是在肾功能评估中。颗粒增强比浊免疫检测（PETIA）可测量Cystatin C存在下抗原抗体复合物形成引起的浊度，操作简单且Cystatin C效益高，适合临床实验室常规使用。浓度，尤其是在大规模测试中。

扩大Cystatin C照护现场测量的使用

在实验室环境中，Cystatin C测量是在配备专业设备和训练有素的工作人员的临床实验室中进行的。从患者身上采集血液样本，并使用先进的测试设备进行处理，以测量Cystatin C的浓度。这些环境允许进行深入分析和精确测量，通常提供更广泛的测试和更高的吞吐量，但与照护现场环境相比，结果时间更慢，可能需要一些时间。在照护现场环境中，Cystatin C测量在患者现场或患者附近进行，例如在医生办公室、医生办公室或医院的床边。Cystatin C就地检验旨在提供快速结果，以便医疗保健提供者能够立即做出临床决策。这些测试通常更简单、更快，并且需要最少的设备或专门培训。这些测试对于快速评估以及在快速结果对于立即治疗决策至关重要的情况下非常有用。

样本类型尿液样本，在Cystatin C测量中起着重要作用，可测量样本中肌酸酐的含量

Cystatin C测量采用血液样本，特别是血清和血浆。这些检体对于评估作为肾功能生物标记的Cystatin C水平至关重要。血液检体为临床医生提供诊断和监测病情（包括慢性肾臟病）的宝贵信息，并提供对肾臟健康和过程的深入了解。用于测量Cystatin C 的尿液检体用于测量尿液中Cystatin C的浓度。尿液中的Cystatin C显示肾小管功能障碍和其他肾臟问题。选择血液或尿液作为检测法Cystatin C的方法通常取决于患者个体的需求和情况。这些方法提供了有价值的诊断见解，血液检测提供了更传统的方法，尿液检测在无法进行血液采样时提供了可行的替代方法。

扩大Cystatin C测量在肾功能诊断的应用

出于诊断目的，Cystatin C测量对于评估肾功能至关重要，可以及早发现和监测肾臟疾病。在临床实践中，它用于鑑别诊断、风险分层和个人化医疗保健。在研究和开发中，Cystatin C测量对于寻找生物标记以了解肾功能和疾病至关重要。它应用于临床试验和研究，以评估干预措施对肾臟健康的影响，并支持探索有助于肾臟研究进展的疾病机制。

扩大Cystatin C测量在最终用户学术研究中心生物标记研究的应用

学术研究中心经常使用Cystatin C测量来研究肾功能和疾病。这包括研究早期检测的生物标记、了解肾臟疾病的进展以及评估潜在治疗方法的有效性。学术研究人员可以在生物标记发现计划中使用Cystatin C测量来识别肾功能和疾病的新指标。诊断实验室通常采用Cystatin C测量作为综合肾功能测试组的一部分。这有助于早期发现肾功能障碍，并为临床医生提供患者管理的宝贵资讯。对于慢性肾臟病，诊断实验室利用Cystatin C测量来持续监测患者。定期检查可以追踪肾功能的变化，并及时调整治疗方案。在医院和诊所，Cystatin C测量可帮助医疗保健专业人员做出有关肾功能的临床决策。数值升高需要进一步调查和调整患者照护。学术研究中心使用Cystatin C测量来推进科学知识，诊断实验室使用它进行常规肾功能检测和鑑别诊断。医院和诊所使用Cystatin C测量来进行肾臟疾病患者的临床决策和管理。

区域洞察

北美，尤其是美国，拥有主要的医疗保健和诊断公司、研究机构和成熟的医疗基础设施，对Cystatin C测量市场做出了重大贡献。此外，美国食品药物管理局(FDA) 和加拿大卫生署等政府监管机构的严格监管标准在Cystatin C测量的产品核可中发挥重要作用。在南美洲，人们对疾病早期诊断重要性的认识不断提高以及医疗保健部门的不断发展预计将导致对Cystatin C测量的需求不断增长。在欧洲，德国、法国、瑞士和英国等国家由于其完善的医疗基础设施、高支出以及对製药和生物技术领域技术进步的关注，正在为更大程度地采用Cystatin C测量做出贡献。在中东和非洲，由于人口成长导致慢性病盛行率不断上升，以及医疗保健领域的大量投资提高了诊断能力，预计将推动该地区对Cystatin C测量的采用。在包括中国和日本在内的亚太地区国家，老年人口的增加和慢性病盛行率的上升正在促进市场的扩张。在中国、印度和澳洲等国家，人们对肾臟疾病的认识不断提高，政府和当地医疗保健公司积极进行健康筛检工作，推动了对Cystatin C测量等诊断测试的需求。在印尼、泰国和越南等新兴国家，经济发展、医疗保健普及以及对预防性医疗保健的重视正在推动Cystatin C测量的采用。

FPNV定位矩阵

FPNV 定位矩阵对于评估Cystatin C测量市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对Cystatin C测量市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.Cystatin C测量市场的市场规模和预测是多少？

2.在Cystatin C测量市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.Cystatin C测量市场的技术趋势和法规结构是什么？

4.Cystatin C检测市场主要厂商的市场占有率是多少？

5.进入Cystatin C检测市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肾臟疾病盛行率上升和老年人口增加
      • 积极投资肾臟疾病医疗基础设施
    • 抑制因素
      • Cystatin C检测的开发成本高且产品召回率高
    • 机会
      • Cystatin C测量试验的进展
      • 新研究采用Cystatin C测试取代基于肌酸酐的测试
    • 任务
      • 缺乏熟练的实验室专业人员以及与Cystatin C测量相关的技术挑战
  • 市场区隔分析
    • 产品：消费者首选的Cystatin C分析仪，用于诊断和状态监测
    • 方法：扩大酵素结合免疫吸附检测法(ELISA) 在Cystatin C测定中的应用
    • 背景：扩大Cystatin C检测在照护现场环境中的使用
    • 样本类型：尿液样本对Cystatin C测量的重要作用，用于测量样本中肌酸酐的量
    • 应用：扩大Cystatin C测定在肾功能诊断的应用
    • 最终用户：扩大Cystatin C测定在学术研究中心的生物标记研究中的使用
  • 市场趋势分析
    • 建立医疗保健基础设施并专注于在美洲Cystatin C测量解决方案商业化
    • 政府支持的减轻亚太地区肾臟疾病负担的计划
    • 专注于在 EMEA 地区开发和扩展新的Cystatin C检测产品
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第 6 章Cystatin C测量市场：副产品

  • 分析仪
  • 套件
  • 试剂

第 7 章Cystatin C测量市场：按方法

  • 化学冷光免疫检测
  • 酵素免疫分析法
  • 萤光测定
  • 颗粒增强免疫检测
  • 颗粒增强免疫检测

第 8 章Cystatin C测量市场（依样本类型）

  • 血
  • 尿

第 9 章Cystatin C测量市场的建立

  • 实验室设置
  • 照护现场设置

第 10 章Cystatin C测量市场：依应用分类

  • 使用诊断
  • 研究与开发

第 11 章Cystatin C测量市场：依最终用户分类

  • 学术研究中心
  • 诊断实验室
  • 医院/诊所

第十二章 美洲Cystatin C测量市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区Cystatin C测量市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第14章 欧洲、中东和非洲的Cystatin C测量市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Jana Care 融资 600 万美元用于自我血液检测商业化
    • RhodesMed 宣布在马哈拉斯特拉邦开设第一个病理中心
    • Renalyse 完成 100 万欧元资金筹措，GENESIS Ventures 参与
    • Renalytix 选择 EVERSANA 扩大 KidneyIntelX 的商业化，用于 2 型糖尿病患者肾臟疾病的早期预后检测
    • 欧洲新的 eGFRCystatin C公式可能更准确
    • Jana Care 与罗氏合作开发和分销血液检测平台，以改善慢性肾臟病和心臟病患者的远距护理
    • Gentian Diagnostics ASA 签署Cystatin C经销协议
    • Bloom Diagnostics 宣布新的肾臟测试

第16章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-2E76C3E47F4F

[194 Pages Report] The Cystatin C Assay Market size was estimated at USD 427.47 million in 2023 and expected to reach USD 459.83 million in 2024, at a CAGR 7.24% to reach USD 697.41 million by 2030.

The cystatin C assay is a laboratory test utilized to measure the levels of cystatin C, a protein produced by nearly all cells in the body. It is most useful in exceptional cases where creatinine measurement could be misleading. The increasing prevalence of kidney diseases and the growing geriatric population drive the need for cystatin C assay. Furthermore, the increasing availability and clinical adoption of cystatin C with the introduction of advanced automated testing methods have led to its market growth. In contrast, the high manufacturing costs of cystatin C assays and strict interpretation guidelines restrict their adoption. However, several vendors are investing in R&D to overcome its issues. Furthermore, advancements in diagnostics technologies, emerging research, and ongoing publishing of clinical guidelines for cystatin C assay provide substantial market growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 427.47 million
Estimated Year [2024] USD 459.83 million
Forecast Year [2030] USD 697.41 million
CAGR (%) 7.24%

Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions

A cystatin C analyzer is a medical device used to measure cystatin c concentration. This device is crucial for diagnosing and monitoring conditions such as kidney disease. Cystatin C kits are designed to accurately measure human cystatin c in cell culture supernatants, serum, plasma, saliva, urine, and human milk. Cystatin C reagents are recognized as being of the highest quality, producing accurate and precise results. It is a chemical substance used in the laboratory to measure cystatin C levels in the sample. A wide range of methods and formats provide greater flexibility and choice for any laboratory size.

Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays

The enzyme-linked immunosorbent assay (ELISA) method involves using antibodies using antibodies to detect and quantify the cystatin c levels in a sample. ELISA is known for its sensitivity and specificity, making it a widely used method in clinical laboratories for assessing cystatin C levels as a marker for renal function. A chemiluminescent immunoassay for cystatin C offers high sensitivity and wide dynamic range and is often automated, enabling efficient high-throughput testing. It is commonly used in clinical laboratories for its precision and accuracy in quantifying cystatin C levels. Immunofluorescence assay utilizes fluorescent dyes or proteins to label cystatin C antibodies, and fluorescence is detected under a microscope or specialized instrument. It is useful in research settings and specific clinical scenarios requiring visual confirmation of cystatin C presence. Particle-enhanced nephelometric immunoassay (PENIA) offers high sensitivity and precision, is suitable for low-concentration samples, and is widely used in clinical laboratories for its accuracy and reliability in quantifying cystatin C, especially in renal function assessment. Particle-enhanced turbidimetric immunoassay (PETIA) measures the degree of turbidity caused by the formation of antigen-antibody complexes in the presence of cystatin C. It is simple, cost-effective, suitable for routine clinical use, and commonly employed in clinical laboratories to quantify cystatin C levels, especially in large-scale testing.

Setting: Expanding usage of point-of-care setting for cystatin C assays

In a laboratory setting, cystatin C assay is performed in clinical laboratories equipped with specialized equipment and trained personnel. Blood samples are collected from patients and then processed using advanced laboratory instruments to measure the levels of cystatin C. This setting allows for meticulous analysis and precise measurements, often offering a wider range of tests and higher throughput, although it might take longer to generate results compared to point-of-care settings. In a point-of-care setting, the cystatin C assay is conducted at or near the patient's location, such as within a clinic, doctor's office, or at the bedside in a hospital. Point-of-care tests for cystatin C are designed to provide rapid results, allowing healthcare providers to make immediate clinical decisions. These tests are often simpler, quicker, and require minimal equipment or specialized training. They are beneficial for quick assessments or situations where rapid results are crucial for immediate treatment decisions.

Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample

The cystatin C assay employs blood samples, specifically serum and plasma. These samples are vital for evaluating cystatin C levels as a biomarker for kidney function. Blood samples provide clinicians with valuable information to diagnose and monitor conditions, including chronic kidney disease, offering insights into renal health and processes. Urine samples for cystatin c assay involve measuring the concentration of cystatin c in the urine. Cystatin C in urine indicates tubular dysfunction and other renal issues.The choice between blood and urine assays for cystatin C often relies on individual patient needs and circumstances. These methods provide valuable diagnostic insight, with blood assays offering a more traditional approach and urine assays providing a viable alternative when blood sampling is untenable.

Application: Increasing application of cystatin C assays for diagnosis of renal function

For diagnostic use, cystatin C assays are vital for assessing renal function, enabling early detection and monitoring of kidney diseases. It is used in differential diagnosis, risk stratification, and personalized healthcare in clinical settings. For research & development, cystatin C assays are integral in biomarker discovery for understanding kidney function and diseases. It is applied in clinical trials and studies to evaluate the impact of interventions on kidney health, and supports the exploration of disease mechanisms, contributing to advancements in renal research.

End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers

Academic research centers often utilize cystatin C assays to investigate kidney function and diseases. This includes studying biomarkers for early detection, understanding the progression of renal disorders, and assessing the effectiveness of potential treatments. Academic researchers can use cystatin C assays in biomarker discovery projects to identify novel indicators of kidney function or diseases. Diagnostic laboratories routinely employ cystatin C assays as part of comprehensive renal function testing panels. This helps in the early detection of kidney dysfunction and provides clinicians with valuable information for patient management. In cases of chronic kidney diseases, diagnostic laboratories utilize cystatin C assays for ongoing monitoring of patients. Regular testing helps track changes in kidney function and allows for timely adjustments to treatment plans. In hospitals and clinics, cystatin C assays aid healthcare professionals in making clinical decisions related to kidney function. Elevated levels may prompt further investigation or adjustments in patient care. The objective of academic research centers to use cystatin C assays is to focus on advancing scientific knowledge, while diagnostic laboratories use it for routine kidney function testing and differential diagnosis. Hospitals & clinics use cystatin C assays for clinical decision-making and management of patients with kidney disorders.

Regional Insights

In North America, particularly in the U.S., the presence of major healthcare and diagnostic companies, research institutions, and well-established healthcare infrastructure is a significant contributor to the cystatin C assay market. Moreover, stringent regulatory standards laid by government regulatory agencies, including the U.S. Food and Drug Administration (FDA) and Health Canada, play a crucial role in product approvals for cystatin c assay. In South America, increasing awareness about the importance of early disease diagnosis and a growing healthcare sector is expected to contribute to the expanding need for cystatin C assay. In Europe, countries such as Germany, France, Switzerland, and the United Kingdom are contributing to the growing adoption of cystatin C assay as they have well-established healthcare infrastructure with high spending and a focus on technological advancements in the pharmaceutical and biotechnology sectors. In the Middle East and Africa, the growing prevalence of chronic diseases with increasing population and a focus on improving diagnostic capabilities with investing heavily in the healthcare sector is expected to bolster the usage of cystatin C assay in the region. In APAC countries, including China and Japan, the increasing number of geriatric residents and the rising prevalence of chronic diseases contribute to the expansion of the market. In countries including China, India, and Australia, increasing awareness of kidney diseases and proactive health screening initiatives by government and regional healthcare companies increase the need for diagnostic tests such as cystatin c assay. In emerging nations such as Indonesia, Thailand, and Vietnam, economic development, expanding healthcare access, and an emphasis on preventive healthcare support the application of cystatin C assay in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cystatin C Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cystatin C Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Analyzer
    • Kits
    • Reagents
  • Method
    • Chemiluminescence Immunoassay
    • Enzyme linked Immunosorbent Assay
    • Immunofluorescence Assay
    • Particle-enhanced Nephelometric Immunoassay
    • Particle-enhanced Turbidimetric Immunoassay
  • Sample Type
    • Blood
    • Urine
  • Setting
    • Laboratory Setting
    • Point of Care Setting
  • Application
    • Diagnosis Use
    • Research & Development
  • End-user
    • Academic Research Centers
    • Diagnostic Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cystatin C Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cystatin C Assay Market?

3. What are the technology trends and regulatory frameworks in the Cystatin C Assay Market?

4. What is the market share of the leading vendors in the Cystatin C Assay Market?

5. Which modes and strategic moves are suitable for entering the Cystatin C Assay Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
      • 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in cystatin C assay testing
      • 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
    • 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
    • 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
    • 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
    • 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
    • 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established healthcare infrastructure coupled with emphasis on commercializing Cystatin C Assay solutions in the Americas
    • 5.3.2. Supportive government programs to reduce the burden of renal disorders in the Asia-Pacific region
    • 5.3.3. Growing focus on developing and expanding novel cystatin C assays products in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Cystatin C Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzer
  • 6.3. Kits
  • 6.4. Reagents

7. Cystatin C Assay Market, by Method

  • 7.1. Introduction
  • 7.2. Chemiluminescence Immunoassay
  • 7.3. Enzyme linked Immunosorbent Assay
  • 7.4. Immunofluorescence Assay
  • 7.5. Particle-enhanced Nephelometric Immunoassay
  • 7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Urine

9. Cystatin C Assay Market, by Setting

  • 9.1. Introduction
  • 9.2. Laboratory Setting
  • 9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnosis Use
  • 10.3. Research & Development

11. Cystatin C Assay Market, by End-user

  • 11.1. Introduction
  • 11.2. Academic Research Centers
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cystatin C Assay Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
    • 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
    • 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
    • 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
    • 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
    • 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
    • 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
    • 15.3.8. Bloom Diagnostics Launches New Kidney Test

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. CYSTATIN C ASSAY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 27. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2023 (USD THOUSAND)
  • TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2024-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 30. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 32. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 33. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 34. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 35. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 36. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 37. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 38. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 39. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 40. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 41. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 42. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 43. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 44. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 45. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 46. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 47. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 48. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 49. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 50. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 51. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 52. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 53. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 54. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 55. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 56. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 57. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 58. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 59. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 60. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 61. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 62. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 63. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 64. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 65. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 66. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 67. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 68. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 69. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 70. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 71. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 72. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 73. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 74. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 75. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 76. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 77. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 78. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 79. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 80. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 81. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 82. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 83. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 84. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 85. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 86. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 87. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 88. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 89. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 90. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 91. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 92. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 93. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 94. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 95. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 96. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 97. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 98. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 99. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 100. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 101. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 102. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 103. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 104. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 105. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 106. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 107. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 108. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 109. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 110. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 111. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 112. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 113. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 114. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 115. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 116. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 117. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 118. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 119. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 120. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 121. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 122. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 123. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 124. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 125. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 126. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 127. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
  • TABLE 128. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
  • TABLE 129. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 130. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 131. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 132. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 133. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 134. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 135. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 136. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 137. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 138. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 139. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 140. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 141. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 142. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 143. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 144. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 145. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 146. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 147. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 148. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 149. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 150. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 151. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 152. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 153. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 154. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 155. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 156. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 157. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 158. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 159. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 160. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 161. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 162. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 163. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 164. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 165. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 166. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 167. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 168. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 169. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 170. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 171. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 172. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 173. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 174. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 175. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 176. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 177. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 178. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 179. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 180. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 181. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 182. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 183. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 184. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 185. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 186. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 187. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 188. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 189. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 190. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 191. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 192. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 193. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 194. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 195. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 196. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 197. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 198. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 199. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 200. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 201. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 202. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 203. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 204. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 205. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 206. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 207. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 208. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 209. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 210. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 211. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 212. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 213. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 214. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 215. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 216. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 217. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 218. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 219. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 220. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 221. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 222. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 223. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 224. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 225. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 226. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 227. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 228. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 229. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 230. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 231. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 232. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 233. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 234. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 235. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 236. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 237. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 238. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 239. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 240. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 241. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 242. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 243. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 244. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 245. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 246. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 247. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 248. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 249. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 250. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 251. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 252. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 253. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 254. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 255. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 256. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 257. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 258. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 259. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 260. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 261. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 262. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 263. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 264. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 265. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 266. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 267. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 268. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 269. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 270. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 271. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 272. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 273. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 274. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 275. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 276. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 277. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 278. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 279. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 280. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 281. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 282. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 283. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 284. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 285. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 286. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 301. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 302. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 303. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 304. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 305. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 306. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 307. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 308. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 309. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 310. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 311. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 312. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 313. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 314. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 315. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 316. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 317. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 318. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 319. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 320. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 321. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 322. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 323. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 324. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 325. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 326. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 327. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 328. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 329. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 330. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 331. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 332. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 333. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 334. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 335. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 336. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 337. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 338. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 339. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 340. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 341. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 342. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 343. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 344. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 345. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 346. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 347. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 348. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 349. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 350. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 351. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 352. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2024-2030 (USD THOUSAND)
  • TABLE 353. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD THOUSAND)
  • TABLE 354. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD THOUSAND)
  • TABLE 355. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2023 (USD THOUSAND)
  • TABLE 356. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2024-2030 (USD THOUSAND)
  • TABLE 357. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 358. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 359. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 360. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 361. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
  • TABLE 362. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
  • TABLE 363. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2023 (USD THOUSAND)
  • TABLE 364. ISRAEL CYSTATIN C ASSAY